9.42
+0.16
+(1.73%)
At close: January 31 at 2:24:29 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
100,105.00
101,783.00
101,661.00
58,455.00
Total Liabilities Net Minority Interest
6,789.00
7,194.00
9,427.00
6,240.00
Total Equity Gross Minority Interest
93,316.00
94,589.00
92,234.00
52,215.00
Total Capitalization
93,316.00
94,589.00
92,234.00
52,215.00
Common Stock Equity
93,316.00
94,589.00
92,234.00
52,215.00
Net Tangible Assets
17,323.00
29,085.00
35,575.00
5,034.00
Working Capital
17,008.00
28,804.00
35,392.00
4,718.00
Invested Capital
93,316.00
94,589.00
92,234.00
52,215.00
Tangible Book Value
17,323.00
29,085.00
35,575.00
5,034.00
Share Issued
21,490.82
21,490.82
21,490.82
18,706.98
Ordinary Shares Number
21,490.82
21,490.82
21,490.82
18,706.98
12/31/2020 - 6/3/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DIABIO.ST Diagonal Bio AB (publ)
0.0189
-5.50%
AZT.OL ArcticZymes Technologies ASA
14.56
+0.14%
OTLC Oncotelic Therapeutics, Inc.
0.0300
-0.99%
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
HNSA.ST Hansa Biopharma AB (publ)
34.46
+3.73%
CAMX.ST Camurus AB (publ)
596.00
-0.17%
ANNX Annexon, Inc.
3.8400
-4.95%
GMAB.CO Genmab A/S
1,424.50
+1.03%
EVAX Evaxion Biotech A/S
2.4550
-0.61%